Today: 7 February 2026
Subscribe
Browse Category

Stock Market News News 20 December 2025

AppLovin (APP) Stock Update Dec. 20, 2025: Why Shares Are Surging, Fresh Analyst Targets, and the Next Catalysts

AppLovin (APP) Stock Update Dec. 20, 2025: Why Shares Are Surging, Fresh Analyst Targets, and the Next Catalysts

AppLovin Corporation (NASDAQ: APP) has become one of the market’s most closely watched adtech and AI-driven marketing stories—especially as investors debate how much runway remains in its e-commerce expansion and how durable its mobile gaming advertising strength will be into 2026. As of Dec. 20, 2025 (Saturday), U.S. markets are closed, so the most recent official close is Friday, Dec. 19. AppLovin stock finished that session at $721.37, up about 3.9% on the day, with after-hours trading around $725 in some feeds. MarketBeat+2Stock Analysis+2 Below is a comprehensive, publication-ready roundup of today’s key AppLovin stock news drivers, current forecasts and
20 December 2025
·····
CoreWeave (CRWV) Stock News and Forecasts for Dec. 20, 2025: DOE “Genesis Mission” Boosts Shares as Analysts Debate AI Data-Center Risks

CoreWeave (CRWV) Stock News and Forecasts for Dec. 20, 2025: DOE “Genesis Mission” Boosts Shares as Analysts Debate AI Data-Center Risks

CoreWeave, Inc. (NASDAQ: CRWV) ends the week back in the spotlight after a sharp Friday rebound that partially reversed a bruising late-2025 selloff. As of the Dec. 19, 2025 close (the last trading session ahead of Dec. 20), CoreWeave shares finished around $83, up roughly 22% on the day, according to MarketBeat’s end-of-day quote. MarketBeat The catalyst wasn’t a single headline—it was a “stack” of market-moving signals that hit within roughly 24–48 hours: That rebound arrives after weeks of volatile trading tied to a broader market debate: whether the AI infrastructure buildout is a durable, cash-generating megatrend—or the early innings
20 December 2025
·····
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine, Inc. (NASDAQ: IRON) stock is seeing a classic “biotech catalyst storm” on Dec. 20, 2025: big intraday swings, headline-driven volatility, and analysts arguing over whether the market is repricing risk or merely repricing uncertainty. As of the latest trading data available, IRON was around $80.04, down roughly 11.5% versus the prior close, after trading as high as $94.60 and as low as $71.46 on heavy volume (about 4.22 million shares). The immediate trigger: a report-driven debate about the FDA’s new fast-track voucher process and whether Disc’s lead drug candidate, bitopertin, remains on the clean, accelerated path bulls were
20 December 2025
·····
Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

December 20, 2025 — Western Digital Corporation (NASDAQ: WDC) is closing out 2025 as one of the market’s most talked-about “infrastructure for AI” plays, with shares hovering around $181 after a volatile, high-volume session that saw the stock trade between roughly $176 and $185. Behind the move is a rare combination of catalysts hitting at once: Western Digital’s imminent addition to the Nasdaq-100, a fresh wave of Wall Street price-target hikes, and a business narrative increasingly tied to AI data-center storage demand—the kind of “picks-and-shovels” theme investors have chased across tech in 2025. ir.nasdaq.com+2Investing.com+2 Below is a detailed roundup of
20 December 2025
····
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Corporation (NASDAQ: RKLB) closed at a fresh all-time high on Friday, December 19, after landing its largest contract to date: a major U.S. Space Force-linked award to build missile-defense satellites for the Space Development Agency (SDA). The move capped off a volatile, news-packed stretch for the company—one that also included a high-profile U.S. Space Force launch completed months ahead of schedule, a first dedicated mission for Japan’s space agency, and continued drumbeat updates on Rocket Lab’s next-generation Neutron rocket program. SDA+3MarketWatch+3Investing.com+3 As of Saturday, December 20, 2025 (U.S. markets closed), the latest official close being digested by investors
20 December 2025
·····
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December 20, 2025, EWTX is being widely quoted around $25.55—a level reached after a powerful jump in the prior U.S. session. StockAnalysis+1 What matters for readers tracking the stock isn’t just the price print. It’s the why: a late-stage neuromuscular story (sevasemten), a closely watched cardiovascular program (EDG-7500), and a pipeline that can re-rate quickly on clinical updates—up or down. PR
20 December 2025
···
Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Inc. (NASDAQ: FLY) is back in the spotlight as of Saturday, December 20, 2025—not because markets are open today (they aren’t), but because Friday’s session (Dec. 19) delivered the kind of price action that turns a newly public space company into weekend reading. FLY stock surged 22.82% on Dec. 19 to close at $24.65, after climbing 8.31% the day before. StockAnalysis+1 That two-day jump is now colliding with a dense stack of “investor attention catalysts”: a fresh analyst initiation, updated Wall Street price targets, a resale registration tied to the SciTec acquisition, and a still-active securities lawsuit timeline.
20 December 2025
····
Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA, Inc. (NYSE: FIX) heads into the final full week of 2025 with two headline catalysts in focus: a year-end leadership transition and a pending move into the S&P 500—both of which are shaping weekend headlines, analyst commentary, and positioning ahead of Monday’s open. As of the most recently available quote tied to the last U.S. trading session (Friday, Dec. 19, 2025), FIX traded around $940.74, up roughly 2.36% on the day. MarketScreener What’s driving Comfort Systems USA stock on Dec. 20, 2025 1) Comfort Systems confirms leadership changes effective at year-end Late Friday, the company announced a
20 December 2025
···
Hong Kong Stock Exchange (HKEX) News on Dec. 20, 2025: Board Lot Reform, Public Float Rules, IPO Pipeline and 2026 Forecasts

Hong Kong Stock Exchange (HKEX) News on Dec. 20, 2025: Board Lot Reform, Public Float Rules, IPO Pipeline and 2026 Forecasts

HONG KONG — As of December 20, 2025, the Hong Kong Stock Exchange is heading into 2026 with a familiar mix of ambition and operational fine print: boost market liquidity, lower barriers for retail investors, and keep the IPO machine moving—without letting standards slip. Over the past week, Hong Kong Exchanges and Clearing (HKEX)—the exchange operator—has launched a major consultation to standardise “board lot” trading units, published final conclusions on tightened ongoing public float rules that start in January 2026, and continued to host headline-grabbing listings as the city’s IPO rebound gains credibility. Hong Kong Exchanges and Clearing+2Hong Kong Exchanges
20 December 2025
··
CoreWeave (CRWV) Stock Surges on Citi Buy Call and DOE Genesis Mission: Latest News, Analyst Targets, and 2026 Outlook

CoreWeave (CRWV) Stock Surges on Citi Buy Call and DOE Genesis Mission: Latest News, Analyst Targets, and 2026 Outlook

December 20, 2025 — CoreWeave, Inc. (Nasdaq: CRWV) is back in the spotlight after a sharp rally in the latest U.S. trading session. The AI cloud specialist’s shares last traded around $83, after swinging between roughly $70.70 and $84.19 on the day and posting unusually heavy volume (about 70.6 million shares). That move didn’t happen in a vacuum. Over the past 10 days, CoreWeave stock has been whipsawed by a familiar mix of catalysts for “AI infrastructure” names: analyst coverage shifts, government partnerships, construction-and-capacity headlines, and investor unease about the sector’s debt-funded buildout. Here’s what matters for CRWV right now,
20 December 2025
·····
Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

December 20, 2025 — Ferrovial SE (NASDAQ: FER; Spain: FER; Euronext Amsterdam: FER) is ending the week in a very different universe than most “infrastructure” stocks: on Monday, December 22, 2025, the company is set to join the Nasdaq-100, a club better known for megacap tech than toll roads. Reuters+1 That index milestone lands alongside two shareholder-friendly moves that help explain why Ferrovial stock has been under an unusually bright spotlight in December: a new €800 million share repurchase program and a cash dividend scheduled to be paid from December 22. PR Newswire+1 With U.S.-listed shares closing at $66.39 on
20 December 2025
·····
Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is having the kind of week biotech traders both crave and fear: a sudden, definitive catalyst that snaps the stock to a new reality overnight. On Friday, December 19, shares jumped about 30% and hovered around $14.18, after BioMarin Pharmaceutical announced a $14.50-per-share all-cash acquisition valuing Amicus at roughly $4.8 billion. Reuters+1 Because it’s a cash buyout, the story for Amicus stock is now less about “quarterly beats” and more about a single question: Will the deal close on time and on the stated terms? And that question—plus a few spicy subplots like patent litigation
20 December 2025
·····
1 … 19 20 21 22 23 … 51

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop